Subscribe to RSS
DOI: 10.1055/s-0029-1219819
Copper(II) Acetate Promoted Intramolecular Carboamination of Alkenes: An Efficient Synthesis of Pentacyclic Sultams
Publication History
Publication Date:
09 April 2010 (online)
Abstract
Copper(II) acetate promoted intramolecular carboamination reactions of 5-allyl-N-sulfonylated coumarins and quinolones have been described. The hitherto unreported pentacyclic sultams, obtained by the oxidative cyclization in high yields, are potential intermediates in the synthesis of nitrogen-containing heterocyclic compounds.
Key words
aza-Claisen rearrangement - sultams - copper(II) acetate - oxidative cyclization - intramolecular carboamination
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Drews J. Science 2000, 287: 1960 -
1b
Scozzafava A.Owa T.Mastrolorenzo A.Supuran CT. Curr. Med. Chem. 2003, 10: 925 -
2a
de Bont DBA.Sliedregt-Bol KM.Hofmeyer LJF.Liskamp RMJ. Bioorg. Med. Chem. 1999, 7: 1043 -
2b
Roush WR.Gwaltney SL.Cheng J.Scheidt KA.McKerrow JH.Hansell E. J. Am. Chem. Soc. 1998, 120: 10994 - 3
Brashear KM.Cook JJ.Bednar B.Bednar RA.Gould RJ.Halczenko W.Holahan MA.Lynch RJ.Hartman GD.Hutchinson JH. Bioorg. Med. Chem. Lett. 1997, 7: 2793 - 4
Radkiewicz JL.McAllister MA.Goldstein E.Houk KN. J. Org. Chem. 1998, 63: 1419 - 5
Bradbury RH.Bath C.Butlin RJ.Dennis M.Heys C.Hunt SJ.James R.Mortlock AA.Summer NF.Tang EK.Telford B.Whiting E.Wilson C. J. Med. Chem. 1997, 40: 996 - 6
Hanessian S.Sailes H.Therrien E. Tetrahedron 2003, 59: 7047 -
7a
Silvestri R.Marfè G.Artico M.La Regina G.Lavecchia A.Novellino E.Morgante M.Di Stefano C.Catalano G.Filomeni G.Abruzzese E.Ciriolo MR.Russo MA.Amadori S.Cirilli R.La Torre F.Salimei PS. J. Med. Chem. 2006, 49: 5840 -
7b
Lebegue N.Gallet S.Flouquet N.Carato P.Pfeiffer B.Renard P.Léonce S.Pierré A.Chavatte P.Berthelot P. J. Med. Chem. 2005, 48: 7363 - 8
Xie Y.Gong G.Liu Y.Deng S.Rinderspacher A.Branden L.Landry DW. Tetdrahedron Lett. 2008, 49: 2320 - 9
Levy L. Drugs Future 1992, 17: 451 - 10
McKerrecher D,Pike KG, andWaring MJ. inventors; WO 2006125972. - 11
Brzozowski Z.Saczewski F.Neamati N. Bioorg. Med. Chem. Lett. 2006, 16: 5298 - 12
Wroblewski T.Graul A.Castaner J. Drugs Future 1998, 23: 365 - 13
Tanimukai H.Inui M.Harigushi S.Kaneko J. Biochem. Pharmacol. 1965, 14: 961 - 14
Inagaki M.Tsuri T.Jyoyama H.Ono T.Yamada K.Kobayashi M.Hori Y.Arimura A.Yasui K.Ohno K.Kakudo S.Koizumi K.Suzuki R.Kawai S.Kato M.Matsumoto S. J. Med. Chem. 2000, 43: 2040 - 15
Wells GJ.Tao M.Josef KA.Bihovsky R. J. Med. Chem. 2001, 44: 3488 - 16
Oppolzer W. Pure Appl. Chem. 1990, 62: 1241 -
17a
Davis FA.Chen B.-C. Chem. Rev. 1992, 92: 919 -
17b
Differding E.Lang R. Helv. Chim. Acta 1989, 72: 1248 -
18a
Raski SR.Williams RM. Chem. Rev. 1998, 98: 2723 -
18b
Murakami A.Gao G.Omura M.Yano M.Ito C.Furukawa H.Takahasi D.Koshimizu K.Ohigash H. Bioorg. Med. Chem. Lett. 2000, 10: 59 -
18c
Hagen SE.Domagala JM.Heifetz CL.Sanchez JP.Solomon M. J. Med. Chem. 1990, 33: 849 -
18d
Laborde E.Kiely JS.Culbertson TP.Lesheski LE. J. Med. Chem. 1993, 36: 1964 -
18e
Gozalbes R.Brun-Pascaud M.García-Domenech R.Galvez J.Girard P.Doucet J.Derouin F. Antimicrob. Agents Chemother. 2000, 44: 2764 -
19a
Majumdar KC.Chattopadhyay B.Taher A. Synthesis 2007, 3647 -
19b
Majumdar KC.Pal AK.Taher A.Debnath P. Synthesis 2007, 1707 -
19c
Majumdar KC.Chakravorty S.Shyam PK.Taher A. Synthesis 2009, 403 -
19d
Majumdar KC.Debnath P.Taher A.Pal AK. Can J. Chem. 2008, 86: 325 -
19e
Majumdar KC.Taher A.Debnath P. Synthesis 2009, 793 -
20a
Majumdar KC.Debnath P.Taher A. Lett. Org. Chem. 2008, 5: 169 -
20b
Majumdar KC.Chakravorty S.Taher A. Synth. Commun. 2008, 38: 3159 - 21
Silvestri R.Marfè G.Artico M.La Regina G.Lavecchia A.Novellino E.Morgante M.Di Stefano C.Catalano G.Filomeni G.Abruzzese E.Ciriolo MR.Russo MA.Amadori S.Cirilli R.La Torre F.Salimei PS. J. Med. Chem. 2006, 49: 5840 -
22a
Bravo RD.Cánepa AS. Synth. Commun. 2002, 32: 3675 -
22b
Katritzky AR.Wu J.Rachwal S.Rachwal B.Macomber DW.Smith TP. Org. Prep. Proced. Int. 1992, 24: 463 -
22c
Orazi OO.Corral RA.Bravo R.
J. Heterocycl. Chem. 1986, 23: 1701 - 23
Lee J.Zhong Y.-L.Reamer RA.Askin D. Org. Lett. 2003, 5: 4175 - 24
Enders D.Moll A.Bats JW. Eur. J. Org. Chem. 2006, 1271 - 25
Chiacchio U.Corsaro A.Rescifina A.Bkaithan M.Grassi G.Piperno A. Tetrahedron 2001, 57: 3425 -
26a
Greig IR.Trozer MJ.Wright PT. Org. Lett. 2001, 3: 369 -
26b
Plietker B.Seng D.Fröhlich R.Metz P. Tetrahedron 2000, 56: 873 -
26c
Rogatchov VO.Bernsmann H.Schwab P.Fröhlich R.Wibbeling B.Metz P. Tetrahedron Lett. 2002, 43: 4753 -
26d
Wanner J.Harned AM.Probst DA.Poon KWC.Klein TA.Snelgrove KA.Hanson PR. Tetrahedron Lett. 2002, 43: 917 -
27a
Majumdar KC.Mondal S.De N. Synlett 2008, 2851 -
27b
Majumdar KC.Mondal S.De N. Synthesis 2008, 3127 -
27c
Merten S.Fröhlich R.Kataeva O. Adv. Synth. Catal. 2005, 347: 754 -
27d
Vasudevan A.Tseng P.-S.Djuric SW. Tetrahedron Lett. 2006, 47: 8591 - 28
Liu X.-Y.Li C.-H.Che C.-M. Org. Lett. 2006, 8: 2707 -
29a
Padwa A.Flick AC.Leverett CA.Stengel T. J. Org. Chem. 2004, 69: 6377 -
29b
Liang J.-L.Yuan S.-X.Chan PWH.Che C.-M. Org. Lett. 2002, 4: 4507 -
30a
Jimenez-Hopkins M.Hanson PR. Org. Lett. 2008, 10: 2223 -
30b
Hanson PR.Probst DA.Robinson RE.Yau M. Tetrahedron Lett. 1999, 40: 4761 -
31a
Sherman ES.Fuller PH.Kasi D.Chemler SR. J. Org. Chem. 2007, 72: 3896 -
31b
Sherman ES.Chemler SR.Tan TB.Gerlits O. Org. Lett. 2004, 6: 1573 -
31c
Zeng W.Chemler SR. J. Am. Chem. Soc. 2007, 129: 12948 -
31d
Zeng W.Chemler SR. J. Org. Chem. 2008, 73: 6045 -
32a
Fuller PH.Chemler SR. Org. Lett. 2007, 9: 5477 -
32b
Zabawa TP.Chemler SR. Org. Lett. 2007, 9: 2035 -
32c
Zabawa TP.Kasi D.Chemler SR. J. Am. Chem. Soc. 2005, 127: 11250 - 33
Krowichi K.Paillous N.Riviere M.Lattes A. J. Heterocycl. Chem. 1976, 13: 555
References and Notes
Procedure for
the Preparation of Compound 7a
A mixture of compound 5a (100 mg, 0.272 mmol), Cu(OAc)2 (148
mg, 0.815 mmol), and Cs2CO3 (89 mg, 0.272 mmol)
in MeCN (7 mL) was heated in a sealed tube for 7 h. After completion
of the reaction, the reaction mixture was cooled and filtered through
Celite. The solvent was distilled off. The resulting crude product
was purified by column chromatography over silica gel (60-120
mesh) using PE-EtOAc (50:50) mixture as eluent to give
compound 7a. Yield 82%, colorless
solid; mp 276 ˚C. IR (KBr): νmax = 1592,
1663, 2923 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 1.31
(t, J = 7.1
Hz, 3 H), 3.08-3.16 (m, 2 H), 3.49 (dd, J = 9.2,
15.9 Hz, 1 H), 3.75 (dd, J = 5.9,
15.7 Hz, 1 H), 4.28 (q, J = 7.1
Hz, 2 H), 5.07-5.13 (m, 1 H), 6.68 (d, J = 9.5
Hz, 1 H), 7.20 (d, J = 9.0
Hz, 1 H), 7.32 (d, J = 7.5
Hz, 1 H), 7.36 (t, J = 7.5
Hz, 1 H), 7.46 (d, J = 9.5
Hz, 1 H), 7.48 (t, J = 7.5 Hz,
1 H), 7.76 (d, J = 9.1
Hz, 1 H), 7.83 (d, J = 7.5
Hz, 1 H) ppm. ¹³C NMR (100 MHz, CDCl3): δ = 12.7,
33.1, 34.5, 37.6, 61.7, 114.1, 117.3, 119.6, 122.8, 124.3, 127.6,
127.9, 129.7, 132.8, 134.2, 134.4, 136.3, 137.0, 138.5, 161.2 ppm. HRMS: m/z calcd for C20H18N2O3S [M + Na]+:
389.0936; found: 389.0936.